Abstract
Antagonistic interactions in biological systems, which occur when one perturbation blunts the effect of another, are typically interpreted as evidence that the two perturbations impact the same cellular pathway or function. Yet, this interpretation ignores extreme antagonistic interactions wherein an otherwise deleterious perturbation compensates for the function lost because of a prior perturbation. Here, we report on gene-environment interactions involving genetic mutations that are deleterious in a permissive environment but beneficial in a specific environment that restricts growth. These extreme antagonistic interactions constitute gene-environment analogs of synthetic rescues previously observed for gene-gene interactions. Our approach uses two independent adaptive evolution steps to address the lack of experimental methods to systematically identify such extreme interactions. We apply the approach to Escherichia coli by successively adapting it to defined glucose media without and with the antibiotic rifampicin. The approach identified multiple mutations that are beneficial in the presence of rifampicin and deleterious in its absence. The analysis of transcription shows that the antagonistic adaptive mutations repress a stringent response-like transcriptional program, whereas nonantagonistic mutations have an opposite transcriptional profile. Our approach represents a step toward the systematic characterization of extreme antagonistic gene-drug interactions, which can be used to identify targets to select against antibiotic resistance.
Significance
Mutations that are deleterious in the absence of an antibiotic can become beneficial in its presence, which is an example of an extreme antagonistic gene-environment interaction. Such antagonism is of biophysical significance because it reflects nonlocal interactions mediated by intracellular networks rather than direct physical or chemical interactions. We develop and apply a forward-evolution experimental approach to systematically identify these interactions using DNA and RNA sequencing. These analyses reveal differences in the expression of the translational machinery between antagonistic and nonantagonistic mutations. Our findings demonstrate how distinct single-basepair mutations within the same gene can have divergent phenotypic consequences, which give rise to antagonistic interactions that can be explored in addressing antibiotic resistance.
Introduction
Complex biological functions generally emerge from interactions rather than solely from the contributions of individual genes and environmental factors (1). When the function of interest is growth rate, as often considered in fitness studies of single-cell organisms and immortalized cell lines, interactions are typically characterized in terms of whether they enhance or suppress fitness beyond what is predicted from the individual contributions. In the case of gene-gene and drug-drug interactions, pairwise relationships have been systematically identified using gene knockouts and other function-impairing perturbations that effectively query combinatorial effects, through large-scale genetic screens (2, 3, 4, 5, 6), metabolic modeling (7, 8, 9), and collateral sensitivity assays (10, 11, 12). Interactions are classified as synergistic if the double-perturbation fitness is lower than expected from adding the effects of the individual perturbations and antagonistic if higher (13). Synergistic and antagonistic interactions are often interpreted as the result of local mechanisms (2,14,15). In this interpretation, synergistic interactions would relate genes in parallel or redundant pathways. Antagonistic interactions, on the other hand, would concern serial pathways of nonredundant genes or drug targets contributing to the same process. In the latter case, because the loss of either gene alone hampers the process, antagonism would emerge because the fitness impact of the second knockout is directly limited by the first.
An interesting exception to this local picture is the case of synthetic rescues, which are extreme antagonistic interactions in which a gene knockout becomes beneficial (rather than merely less deleterious) when applied after the knockout of another gene (16, 17, 18, 19). Synthetic rescues can be interpreted as a form of sign epistasis (20) between two genetic perturbations that are each individually deleterious, in the sense that the fitness impact of one perturbation changes sign and becomes beneficial in the presence of the other. Although some synthetic rescues can be attributed to toxicity (21, 22, 23, 24, 25, 26), previous work indicates that there exists a combinatorial number of synthetic rescues that are mediated by biochemical networks and involve genes in disparate processes (17,27). Even though synthetic circuits have been used to study the evolution of extreme antagonism (28,29), and the identification of gene-gene combinations exhibiting nonlocal, network-mediated synthetic rescues is ongoing (18,19), an open proposition is whether analogous extreme antagonistic interactions can be systematically identified for gene-environment combinations. Determining the prevalence of extreme antagonism would address a fundamental question in biology concerning the nature of possible interactions between genes and environmental factors. Furthermore, implementing such environmental factors using antibiotic stressors would offer a pathway to design new antibiotic combinations that exhibit collateral sensitivity, as discussed below, because the action of one antibiotic disfavors the acquisition of resistance to another (11,30, 31, 32, 33, 34, 35, 36).
Here, we explore a method to systematically identify extreme antagonistic gene-environment interactions. These interactions occur between genetic and environmental perturbations that, individually, decrease fitness relative to the original condition but that, when combined, increase fitness relative to the environmental change alone. In parallel with synthetic rescues vis-à-vis sign epistasis, extreme antagonistic gene-environment interactions are an outstanding class of environmental sign epistasis (37), in that mutations that are deleterious in a permissive environment become beneficial in a more restrictive environment. We identified these interactions using serial adaptive evolution of Escherichia coli, which consisted of 1) adaptation to a defined glucose medium yielding strains with enhanced fitness, and 2) subsequent adaptation of these strains to antibiotic stress defined by a sublethal concentration of rifampicin (rif). The gene-environment interactions were characterized by comparing the growth fitness of all strains grown in both the presence and the absence of rif, quantifying the cost of resistance (28). Previous studies of the cost of rif resistance have focused on strains cultivated in complex media and reported mutations in the β-subunit of RNA polymerase (rpoB) that result in a fitness disadvantage in such media in the absence of rif (38, 39, 40), though adaptive laboratory evolution experiments in defined glucose media have proved the same mutations to be beneficial (19). Because previously identified adaptive mutations that enhance growth rate and/or rif resistance have pleiotropic effects (41, 42, 43), the global transcriptional consequences of adaptation were further investigated using RNA sequencing (RNA-Seq) before and after each adaptive step. Our experiments and analyses identified mutations in rif-adapted strains that confer growth faster, equal, and slower in the absence of rif compared to that of the parent strain. Of these three groups, the mutations conferring slower growth exhibit extreme antagonistic interactions with rif. These differences in growth can be attributed to widespread transcriptional reprogramming, which we map to broader cellular processes including central metabolism, translation, and a stringent-like response.
We propose that extreme antagonistic gene-environment pairs in which the environmental perturbation is the addition of a drug, such as rif in our experiments, provide targets for the design of antibiotic combinations that can select against resistance. For a pair of extreme antagonistically interacting antibiotics, growth inhibition by a drug combination is weaker than that of one of the drugs alone, meaning that acquisition of resistance to a second drug would cause growth to be suppressed more strongly (44,45)—a phenomenon referred to as collateral sensitivity (11). Although previous studies of collateral sensitivity have found some extreme antagonistic drug pairs (12,30,32,43,46,47), such pairs tend to be rare (35), and are found by directly testing existing antibiotics.
In this article, we apply our method to study antagonism as it relates to rif, for which there appear to be no antagonistic partner antibiotics (11). Resistance to rif, as with antibiotic resistance in general, induces pleiotropic effects on cell physiology that mitigate the action of the drug but are otherwise suboptimal (41,43,48), which we are able to characterize transcriptionally using RNA-Seq in the presence of the drug (to discern adaptative changes) and in the absence of the drug (to identify costs of resistance). We expect transcriptional profiles to be predictive of collateral sensitivity, as has been shown for chemogenomic profiles (49), to the extent that both reflect the molecular mechanisms underlying adaptation and the cost of resistance. These efforts may offer another avenue to manage resistance in bacterial infections that are treated with rif, such as Mycoplasma tuberculosis (50,51). Our approach to find extreme antagonistic gene-drug pairs is scalable and can facilitate the systematic design of antagonistically interacting drug combinations by providing targets—the gene mutations—against which a second drug may be developed. Ultimately, our results provide insights into fundamental and applied aspects of gene-environment interactions.
Materials and Methods
Strain cultivation
All strains used in this study were derived from wild-type (WT) E. coli strain K12 substrain BW25113 (52). The WT strain was suspended in media supplemented with 0.4% w/v glucose (M9G) in triplicate and allowed to grow at 37°C with shaking for 12 h, at which point cultures were diluted to an initial optical density at 600 nm (OD600) of 0.01. Growth and dilution proceeded in this manner for 21–28 days (216–611 generations) in an effort to identify cultures with an enhanced growth rate. At the end of this period of evolution, cultures were plated, colonies were recovered, and whole-genome sequencing (WGS) was performed, yielding Ref mutants with the mapped mutations pykF(C8Y) and rpoB(T1037P).
Selection for spontaneous mutants that restore fast growth in the presence of rif
Mutations that enabled fast growth of Ref strains in M9G with 7.5 μg/mL rif (M9G + rif)—an inhibitory concentration—were selected according to the following procedure: Three independent 5 mL cultures of each of these three strains were cultivated in 20 × 150 mm borosilicate tubes and serially passaged with a starting OD600 of 0.01 for 10 days, shaking at 37°C inclined at a 45° angle at 200 rpm in an Infors Shaker. As before, strains were diluted every 12 h to ensure the cells remained in exponential phase. Spontaneous acquisition of fast growth (i.e., rif-resistance) mutations is random based on published data (53). We observed an enhanced growth rate of the rif-containing cultures, as expected, within 4–5 days (8–10 passages; ∼60–70 generations). Enhanced growth rate of the culture was typically evident after 4–5 days. On the final day of serial passaging, these fast-growing cultures were streaked onto Luria-Bertani agar to isolate single clones. Growth rate measurements of clones confirmed that these “Mut” strains grew faster in M9G + rif than the Ref strains from which they were derived. The genetic identity of the Mut strains was verified by WGS.
Growth rate measurements
To measure growth rates, overnight cultures were first started from freshly grown colonies in 2 mL M9G shaken at 37°C overnight. These starter cultures were diluted in triplicates to OD600 = 0.01 in 2 mL of M9G either with or without 7.5 μg/mL rif in 13 × 100 mm borosilicate tubes and were allowed to grow at 37°C inclined at a 45° angle at 200 rpm in an Infors Shaker. The OD600 was measured approximately every 20 min for at least four independent cultures. Cultures were grown in the absence of light to prevent it from inactivating rif. To obtain growth rates, the log-linear region of the growth curves was fit to the exponential growth equation OD600(t) = 2t/D, where t is time and D is the doubling time, measured in minutes. The mean and standard deviation were calculated for the doubling time ratio of each derived mutant to its corresponding Ref parent. Differences in growth were assessed using a t-test on the ratio of Mut strain growth to Ref strain growth to control for possible differences in media preparation (Table S1).
Mapping rif-adaptive mutations by WGS
We isolated genomic DNA from all E. coli mutant strains presented herein using a standard guanidinium thiocyanate extraction and isopropanol/ethanol precipitation. Briefly, the DNA was randomly sheared, and libraries were prepared for WGS using an Illumina HighSeq 4000 (50-bp single-end reads). The WGS data from each strain were assembled to the E. coli BW25113 WT genome template, and polymorphisms were identified using the breseq analysis pipeline (54). Each sequenced genome library yielded an average of 26 million reads, resulting in average depth of coverage greater than 250 times.
Measuring transcript levels by RNA-Seq
We isolated RNA for sequencing from both Ref strains and their rif-adapted Mut strains in triplicates, in both M9G and M9G + rif; cells were grown and harvested across three separate days. The growth protocol to prepare cultures for RNA isolation was as follows. All strains were cultivated in M9G at 37°C; starter cultures were diluted to OD600 = 0.01 with or without 7.5 μg/mL rif to an OD600 of ∼0.18–0.22. At that point, RNA was extracted by pelleting cells for 30 s and rapidly resuspending the pellets in 1 mL TRIzol (Invitrogen, Life Technologies, Carlsbad, CA). RNA was extracted from the TRIzol suspension using the manufacturer’s protocol. The extracted RNA was next treated with Turbo DNase (Ambion, Life Technologies, Carlsbad, CA) and further purified using an RNA purification kit (Qiagen, Hilden, Germany). Absence of DNA contamination was confirmed by PCR, where the lack of PCR product (∼100 bp in length) relative to a DNA-containing positive control was interpreted as evidence of DNA removal. RNA-Seq libraries were prepared with an Illumina TruSeq stranded RNA kit according to manufacturer’s instructions. Sequencing (50-bp single-end read) was performed on an Illumina HiSeq 4000. Transcript levels were mapped to the E. coli BW25113 WT genome in CLC Genomics Workbench 11 (mismatch cost = 2; insertion cost = 3, deletion cost = 3, length fraction = 0.8, similarity fraction = 0.8). Sequencing reads for all strains, plus and minus rif treatment, have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus database (accession number GEO: GSE136977).
Annotation analysis of transcriptional changes
Determination of differential expression
We compared the transcript levels measured in Mut strains with their respective Ref parents when grown in M9G or M9G + rif. Differential expression was assessed using DESeq2 with the “apeglm” shrinkage estimator yielding log2 fold changes and single-gene p-values (55). These results were further interpreted in the context of Protein Analysis Through Evolutionary Relationships (PANTHER) pathway annotations, PANTHER protein classes, Clusters of Orthologous Groups (COG) identifiers, COG groups, modulons derived from independent component analysis of gene expression, and origons in the genetic network of the Regulon Database (RegulonDB).
PANTHER analysis
The log2 fold changes were input into PANTHER version 14.1 using the E. coli annotations for PANTHER pathways and PANTHER protein classes using a 5% false discovery rate (FDR) threshold for significance (56).
COG analysis
The COG annotation scheme groups genes into five classes, which are subdivided into 23 categories comprising 2161 identifiers based on protein amino acid sequence (57). We interrogated the transcriptional log2 fold changes for enrichment of COG categories and identifiers using a bootstrapping approach. For all n genes associated with a term, we calculated the rank sum and compared this with the rank sums derived from N = 20,000 randomly selected sets of n genes. We calculated the number X of randomly generated rank sums that were smaller than the observed rank sum among the distribution of randomly generated rank sums and determined a p-value using 1 − |1 − 2X/N|. After determining the p-values, we selected terms for further consideration using the Benjamini-Hochberg FDR procedure with a 5% threshold (58).
RegulonDB transcription factor analysis
The network of 212 transcription factors and 1814 regulated genes was defined in the “generegulation_tmp.txt” file downloaded from RegulonDB (59). Annotation enrichment proceeded as before, with the caveat that fold changes were multiplied by the valence of the transcription factor-gene interaction before calculating the rank sum. In addition, any transcription factors passing the 5% FDR threshold but having log2 fold changes in conflict with their downstream targets were excluded from consideration. We record all significant terms and their signs in Table S2 for all Mut strains in both M9G and M9G + rif.
Quantifying the transcriptional signature of the stringent response
We reanalyzed the data contrasting the transcriptional outcomes of (stringent response-inducing) serine hydroxamate treatment between WT E. coli K12 MG1655 and its relA-deficient mutant, which has its stringent response disabled (60). Genes that were differentially regulated between the two strains over the 30-min time-course were determined as follows. Linear regression was used to fit the parameters m and b in a = mt + b, where a is the gene expression vector and t is time. The slope parameters mWT and mΔrelA characterize the rate of transcriptional change in each gene. Then, the difference characterizes the difference in gene regulation between strains having and lacking the stringent response. Let the standard error of and be and , respectively. Then the quantity is normally distributed about zero with unit variance, allowing application of a z-test. This test results in 183 genes that are differentially regulated (117 upregulated and 66 downregulated) between the two conditions (FDR = 5%).
The stringent response-regulated genes are quantified as a vector v indexed by the genes, g, with vg = 1 if gene g is upregulated, −1 if it is downregulated, and 0 otherwise. In our data, each transcriptional response to the adaptive evolution mutations is , where s is an index over Mut strains, a is the gene expression vector with the gene index suppressed, and the logarithm is applied elementwise. We define the stringent response score, S, for a given Mut strain to be . Statistical significance of the scores was assessed by bootstrapping, in which transcriptional responses were shuffled according to their average expression level across both conditions. The elements of Δs were shuffled (with s held fixed) and , the randomized stringent response score, was calculated 10,000 times. Using and to denote the mean and standard deviation of , respectively, the quantity is normally distributed about zero with unit variance. Applying the z-test yields the statistical significance of the score against a null model that takes into account the total amount of transcriptional change across all genes in a given Mut strain.
Origon analysis
Origons are groups of genes reachable from a single master regulator in a transcriptional regulatory network, where master regulators are defined as transcription factors that have no regulatory inputs from other transcription factors (61). Using RegulonDB, we found 82 master regulators and calculated the degree to which they are turned on or off. Let be a subgraph of the regulatory network reachable from master regulator , and let be the fold changes for all genes . Define the sign of each edge, , to be if is an activator of , if is a repressor of , and otherwise, and further define an indexing function , where I() is the indicator function, which is if the argument is true and if false. We are now in a position to calculate , the contributions to the activation of for each node w, recursively. If , the contribution is and because expression of the regulator should contribute to evidence of its activation. For , let be the set of direct predecessor nodes of , and define to be the number of predecessors. Then, , where is a diffusion parameter to attenuate the contribution of longer paths. We calculate starting at , proceeding to its immediate descendants and so on through the network. At each stage, we ensure that all have been calculated before calculating . In the case of cycles, there exists a such that , where is the set of descendants (direct and indirect) of . In this case, we ignore the contribution from all edges , where is the ancestor of and a descendant of , but is only a descendant of . The averaged contributions to the origon expression is , and the total origon expression is .
To compare the origon expression against the random expectation, we reshuffle the nodes in the transcriptional regulatory network according to their in-degree and out-degree. We grouped by each value of in-degree from 0 to 12 and binned nodes with in-degrees higher than 12 together (for a total of 14 bins), and we grouped out-degrees into 24 logarithmically spaced groups. Of the possible 336 bins, 82 are occupied. To randomize, expression values were randomly permuted between nodes in a given bin, thus preserving the degree distributions under randomization. The results of the origon analysis are reported in Table S2.
Modulon analysis
Modulons are groups of genes that contribute to a particular cell function. We projected our transcriptional fold changes onto gene loadings for 92 modulons (62) and compared the resulting projections with those generated by reshuffling the transcriptional data. Modulons were considered significantly differentially expressed if they passed a 1% FDR threshold. Differentially expressed modulons are reported in Table S2.
RNA alignments of ribosomal RNA genes
To examine the RNA-Seq data for signs of transcriptional termination and pausing, we used the wiggle track formatted (WIG) files generated by Rockhopper and the gene locations from NC_000913.3 to calculate a rolling sum (50-bp window) of sequence alignments throughout the genome for both strands. These were averaged over three replicates to generate an alignment profile for each experimental condition. Next, we averaged the alignments for each ribosomal RNA (rRNA) operon over three segments: from the start of the rrs gene to the start of the transfer RNA (tRNA) genes, from the start of the tRNA genes to the start of the rrl gene, and from the start of the rrl gene to the end of the rrf gene. Because the tRNA genes are of different lengths in each operon (from 335 to 447 bp), we rescaled the counts by 447/L, where L is the operon length of the tRNA genes, and linearly interpolated the counts at each base before averaging. Once averaged, these three segments were concatenated into a single vector and annotated with pause sites (63) and termination sites (59,63,64).
Results
Selection of mutations in multiple conditions and their growth consequences
To identify antagonistic gene-environment interactions, we undertook a two-step laboratory evolution approach in which we evolved the WT strain in a defined medium condition and subsequently introduced a sublethal antibiotic stressor (Fig. 1 A; Fig. S1). First, we serially passaged the WT strain in M9G, thereby selecting for mutants with enhanced growth rate in this defined condition. Two Ref strains were sequenced revealing a T1037P mutation in rpoB, which encodes the β-subunit of RNA polymerase (RNAP) or a C8Y mutation in pykF, which encodes pyruvate kinase (Fig. 1 B). These mutations are known to enhance fitness in anaerobic conditions (65) and defined media (66), respectively. Then, each Ref strain was serially passaged in M9G + rif at a concentration that attenuates growth of both strains (Fig. 2). During serial passaging, rif-adapted mutants arose, increasing the overall growth rate of the bulk culture and restoring it to pre-rif levels. We isolated a set of 10 independent rif-adapted Mut strains, five from each Ref strain. The growth outcomes following each step of our lab evolution protocol are shown schematically in Fig. 1 C and Fig. S1. In the context of our experiments, it is the relative growth rate in M9G between the Mut strains and the Ref strain that determines whether the genotype constitutes an extreme antagonistic pair.
Figure 1.
Experimental approach to identify extreme antagonistic interactions. (A) Diagram of our experimental evolution approach, in which WT E. coli BW25113 was adaptively evolved in M9G, yielding two Ref strains with an enhanced growth rate. These Ref strains were then evolved in M9G + rif, yielding five rif-adapted Mut strains per Ref parent. (B) Analysis of rif-adapted Mut strains and their Ref parents. Selected colonies were analyzed for growth in the presence and absence of rif, were subjected to WGS to identify mutations associated with adaptation and were RNA-sequenced to detect changes in transcript abundance. (C) Fitness of the mutants at each stage of the workflow, as measured by growth rate. The growth rate of the rif-adapted strains were compared with that of their Ref parents: Mut strains with significantly slower growth rate in the absence of rif meet the conditions for extreme antagonistic interactions with the addition of rif (Mut3, bottom), whereas Mut strains with growth rate equal (Mut2, middle) or greater (Mut1, top) do not. To see this figure in color, go online.
Figure 2.
Growth rates of the WT, Ref, and Mut strains in the presence and absence of rif. (A and B) Growth rates of the WT strain, Ref strains, and Mut strains derived from the pykF(C8Y) parent (A) and the rpoB(T1037P) parent (B). Solid squares, open squares, and open circles indicate Mut strains that grow faster, as fast as, and slower than the Ref strain in the absence of rif, respectively. (C and D) Growth rate comparisons of the Mut strains with the pykF(C8Y) parent (C) and the rpoB(T1037P) parent (D) in the presence and absence of rif. The means are denoted by symbols and the standard errors of the means are denoted by error bars, which are smaller than the size of the symbol in most cases. To see this figure in color, go online.
The genetic changes in each Mut strain are reported in Table 1. Rif binds at the active site of RNAP and inhibits transcription by preventing translocation (67). We note that the mutations conferring enhanced growth rate in M9G found in the Ref strains—pykF(C8Y) and rpoB(T1037P)—are distinct from those conferring rif resistance in the Mut strains, even though one Ref mutation is in rpoB. Genetic changes that the Mut strains acquired during the process of laboratory evolution in rif all occurred in rpoB and cluster at three previously described E. coli rpoB rif-resistance sites: (I) the RNAP active site where rif binds, (II) the fork domain which ensures basepair fidelity (68); and (N) the DNA entry channel (69). Mutations at sites I and II are reported to effect transcription slippage (68), those at site II can alter termination (70), whereas mutations at the N site decrease the open complex lifetime (69). On average, strains harboring mutations at site I have the fastest growth, followed by those at site II and site N. Because all mutations conferring rif adaptation occur in the same gene, we refer to these strains simply by their amino acid substitutions in rpoB from this point forward.
Table 1.
Mutations and Average Doubling Times for E. coli Strains Grown on M9G in the Presence and Absence of Rif
| Parent Mutation (Ref) | rpoB Residue Substitution (Mut) | Rif-resistance Cluster (67) | Doubling Time M9G (min) | Doubling Time M9G + Rif (min) |
|---|---|---|---|---|
| pykF(C8Y) | – | – | 57 | 120 |
| Q148L | N | 60 | 70 | |
| L511R | I | 63 | 70 | |
| D516G | I | 50 | 57 | |
| H526Y | I | 49 | 53 | |
| I572S | II | 56 | 67 | |
| rpoB(T1037P) | – | – | 51 | 162 |
| Q148L | N | 57 | 73 | |
| S508P | I | 47 | 68 | |
| L511R | I | 54 | 65 | |
| I572N | II | 52 | 84 | |
| I572F | II | 55 | 62 |
To evaluate whether the mutations associated with rif resistance result in fitness costs in the original cultivation condition (i.e., M9G without rif), we categorize the Mut strains by their growth relative to their Ref parents in M9G. The Mut strains may grow 1) faster, revealing that mutations are beneficial in both conditions, possibly reflecting incomplete adaptation of the Ref strains to M9G; 2) equally fast, revealing that the mutations are neutral in the original condition; or 3) slower, revealing that the acquired mutations are deleterious in the first condition, thereby indicating antagonism to rif treatment. These three groups are indicated respectively by orange, purple, and blue colors in the subsequent figures and tables, such as in Fig. 2, which presents the growth rates of each strain, and Table S1, which presents doubling times (color online).
We identified rif-adaptive mutations in each of the growth categories in Fig. 2. The fast-growth mutations consist of the uncharacterized, but previously observed (71), S508P mutation [derived from the rpoB(T1037P) parent], and the well-described mutations (67,68,72,73) at the RNAP active site, D516G and H526Y [derived from the pykF(C8Y) parent]. Compared to their Ref parent, these mutations boost growth rate by 8, 15, and 16%, respectively. Although the set of mutations we observed are not exhaustive, growth-enhancing active site rpoB mutations were not observed in the rpoB(T1037P) Ref strain. The neutral growth mutations—L511R and I572N in rpoB(T1037P) and I572S in pykF(C8Y)—exhibit few transcriptional similarities, and the existing similarities mostly occur between the Mut strains deriving from the same parent (Table S3).
Correlations between transcriptional responses to the rif-adaptive mutations
To define the transcriptional changes associated with the mutation combinations in M9G with and without rif, we measured transcript levels in all Ref and Mut strains using RNA-Seq and determined which genes were differentially expressed between each Mut strain and its Ref parent in both M9G and M9G + rif. We calculated the log2 fold changes in each case and the Pearson correlations between the fold changes in all genes for each pair of conditions.
There are five major trends in the transcriptional correlations shown in Fig. 3. Specifically, 1) all Mut strains are more highly correlated in the presence of rif than in its absence; 2) the mutations at the I572 residue are all correlated, with I572F and I572N being strongly so; 3) the five fastest-growing Mut strains (relative to their Ref parents), S508P, D516G, H526Y, I572N, and I572S, are correlated in the presence and absence of rif; 4) the Q148L and L511R Mut strains derived from different Ref parents have strongly correlated transcriptomes; and 5) all the slow-growing Q148L and L511R Mut transcriptomes are anticorrelated with those of the fast-growing H526Y, D516G, and S508P strains in both conditions. Finding (1) suggests that all Mut strains are in similar biochemical/physiologic space when dealing with the challenge of rif, whereas finding (2) raises the question of how much the Ref strain mutation determines the transcriptional response versus the chemical similarity of the substituted amino acid. Together, findings (3), (4), and (5) imply that mutants that grow faster than their parent Ref converge on a metabolic/physiologic profile that is distinct from mutants with slower growth. The correlation values associated with Fig. 3 are included in Table S3.
Figure 3.
Transcriptional correlations between the Mut strains in M9G and M9G + rif. The color code indicates the correlations between log2 fold changes for each strain in each cultivation condition. The colors of the labels indicate the growth of each Mut strain relative to its Ref parent as defined in Fig. 1.
Patterns in the annotations of differentially expressed genes
To discover functional patterns at the level of gene regulation, we performed annotation analysis using the PANTHER annotations (56), COG annotations (57), modulons (62), and origons (61) from RegulonDB (59). Of the four annotation schemes we consider, the origon analysis is the most fine-grained because it links transcription factors directly with the regulated genes.
We visualize the origon results in Fig. 4, using a network representation. There are two types of network edges: those that connect Mut strains with their differentially expressed origons in M9G and rif and those that connect two origons. The latter edge type indicates that the genes downstream of the master regulator in the origon at the edge tail are contained within the larger origon at the edge head. When considering genes included in origons, we observe all strains except H526Y share phoP downregulation in rif, whereas rpoB(T1037P)-derived strains also share iscR upregulation. In the absence of rif, the cluster I fast-growth strains share zur downregulation and acrR, torR, and slyA upregulation, whereas the I572F and I572N strains share acrR and argR upregulation, and the Q148L strains downregulate phoB.
Figure 4.
Network of significant origon expression changes in the Mut strains relative to Ref parents. Network of activated and repressed transcriptional factors across each Mut genetic background in both M9G and rif. The node color, node shape, node size, edge color, and arrow shape are defined in the legend, in which G(Mut) denotes the growth rate of the Mut strain in M9G. Origons are labeled by their master regulator, and all origons that have a subset relationship with another are placed on the gray background.
The origons that are differentially expressed are generally all implicated in E. coli’s stress response, a trend corroborated by our analysis of modulons. The membrane, GadEWX, and His-tRNA modulons, the latter two of which are implicated in acid stress response and histidine metabolism, respectively, tend to be upregulated in the presence of rif in all strains. Simultaneously, iron utilization and CysB, which are implicated in inorganic sulfate utilization, are generally downregulated. Overall, the results in rif exhibit the convergence in transcription observed in Fig. 3, that is, the transcription factors that Mut strains express in M9G + rif are more similar than those expressed in M9G (Table S2). In the absence of rif, the modulon activation for slow-growth strains show upregulation of RpoS and GadEWX, which is generally anticorrelated with that of fast-growth strains. The anticorrelation is particularly strong in the pykF(C8Y) background, whereas the Q148L and I572F strains show few similarities with each other despite their similar growth phenotype.
As several of the most strongly differentially expressed modulons are in stress response genes, we analyze genes in the stringent response regulon in Fig. 5, given that genes in this regulon were implicated in the evolution of enhanced growth rate in previous experiments (19,69). The E. coli stringent response downregulates genes involved in ribosome synthesis and upregulates genes for amino acid biosynthesis to account for poor nutrient conditions (74). For each transcriptional profile, we calculated a stringent response score by counting the number of genes that change in accordance with their behavior during the stringent response (see Materials and Methods). The fastest-growing Mut strains (D516G, H526Y, and S508P) have transcriptional profiles that resemble the stringent response in the absence of rif, whereas the slower growing strains appear to oppose, or not exhibit, this response. This pattern is particularly pronounced in the pykF(C8Y) background but is not apparent in the rpoB(T1037P) background.
Figure 5.
Stringent response score for each Mut strain. (A and B) Comparison between the observed stringent response scores (triangles) and bootstrapped means (circles) in M9G (A) and M9G + rif (B). Statistically significant cases are denoted by the open symbols, where the error bars correspond to the 95% confidence interval determined by bootstrapping. The color code indicates the Mut strain’s growth rate relative to the Ref parent as defined in Fig. 1. To see this figure in color, go online.
As expected, strains that have a stringent-like transcriptional profile also have decreased transcripts corresponding to ribosomal proteins and 5S rRNA (Fig. S2). These strains show downregulation of genes classified in translation, nucleotide synthesis, and amino acid synthesis COG groups, as well as exhibit fnr activation and significantly enhanced expression of glycolytic genes eno, pgk, pykF, and tpiA. Together, these trends indicate a shift toward overflow metabolism in the faster-growing strains, wherein the majority of ATP production is shifted from oxidative phosphorylation to glycolysis (75). Meanwhile, transcriptional changes in fast-growing strains are anticorrelated with those observed in the slow-growth mutants L511R and Q148L—including three of the four extreme antagonistic cases—possibly reflecting a maintenance of oxidative metabolism, which is more energy efficient (Fig. 5; Table S2). Thus, slow-growth and fast-growth mutations appear to restore growth through different means, and transcriptional changes that emulate those observed in the stringent response are associated with fast growth in the pykF(C8Y) background.
We analyzed the rRNA and ribosomal protein transcript data for all strains (Fig. S2). Rif-adapted mutants harboring I572 mutations and those growing faster than their parent in the absence of rif exhibit decreased amounts of ribosomal protein transcripts in that condition. Increased tRNA and 5S rRNA expression may indicate increased readthrough from more upstream genes in the rRNA locus; decreases of particular genes at the rRNA locus may likewise provide evidence for transcription termination. Elevated expression of amino acid biosynthetic genes may reflect a short-lived open complex. We note that changes in rRNA, reported in Table S4, may reflect an imbalance in ribosomal components, analogous to suboptimal protein/DNA ratios observed in previous extreme antagonistic drug interactions generally (41) and in rif specifically (76).
The varying transcriptional patterns of genes encoding ribosomal components motivated us to more closely examine the reads that mapped to the rRNA loci. This effort was aimed at determining whether the mutant RNAPs exhibited differences in transcriptional efficiency along the operon. In Fig. 6 A, we plot the fold change in read alignment averaged across all rRNA operons for cells cultivated with and without rif. In the presence of rif, we see that both Ref strains have a pronounced peak in the 23S rRNA genes, 720 bp downstream of the rrl transcriptional start site. We note that the height of the peak correlates with the cost of the Ref mutations in rif as the rpoB(T1037P) mutant has slower growth in rif than the pykF(C8Y) mutant and a corresponding higher peak. On the antisense strand, we observe a peak immediately downstream of this site. Rif-resistance mutations appear to decrease the peak height (Fig. 6 B), but the extent to which they do so is correlated with growth only in the rpoB(T1037P)-mutant-derived strains. When cultivated without rif, the change in number of aligning sequences at this site is positively correlated with growth (Fig. 6 C). Although extreme antagonistic mutations appear to constitutively decrease the number of alignments at this site, the fast-growth mutations show substantially decreased alignments only in the presence of rif.
Figure 6.
Fold change in RNA-Seq alignments on both strands averaged across all rRNA operons. (A) Comparison of strains cultivated with and without rif. Data are averaged over the seven rRNA operons whose structure is illustrated by the cartoon above the panel. The top panel shows the sense strand alignment, and the bottom shows the antisense alignment. (B and C) Same as (A), except comparing Mut strains to their Ref parent when cultivated with rif (B) or without rif (C). Bold face strains have dashed lines in the figures and legends define the meaning of the remaining line colors, color backgrounds, and line styles.
We compared the peak locations to those of pause sites (63) and rho-dependent termination sites (64). There is a rho-dependent termination site on the antisense strain 784 bp downstream of the rrl start on the sense strain and a pause site 832 bp downstream of the rrl start proximal to the 720 bp peak. In addition, a secondary site 1349 bp downstream from the rrl start recapitulates the behavior of the primary peak in response rif treatment. When comparing transcription of both Ref strains to their derived Mut strains in rif, decreases in alignments are apparent, but the ordering of strains is distinct from that observed at the 720 bp site. In the absence of rif, alignments increase by a larger amount in the pykF(C8Y) background at this site, which also has a predicted rho-dependent termination site. Beyond these two peaks, the alignment trends show decreases in transcriptional readthrough at the end of genes in fast-growth strains.
Discussion
Our identification of extreme antagonistic interactions reveals the role of molecular mechanisms fomenting gene-environment antagonism, including connections with transcriptional pausing and the stringent response. The application to an antibiotic environment reveals that the rif-adaptive evolution mutations alter the kinetic and thermodynamic properties of RNAP to counter the drug action but hamper growth in the drug’s absence—consistent with the pattern of resistance mutations being pleiotropic (48,49) and suboptimal (41,43). Our study also demonstrates a proof-of-concept approach for the discovery of gene-environment interactions that is scalable to multiple genetic and environmental conditions and sufficiently sensitive to identify extreme antagonistic interactions. A central aspect of our approach is the two steps of adaptive evolution, as schematized in Fig. S1. The first step, preadaptation to the initial environmental condition before applying the environmental perturbation, facilitates the identification of extreme antagonistic interactions (77,78). The second step, adaptation to an antibiotic environment, reveals mutations involved in extreme antagonistic interactions that (as further discussed below) constitute candidate targets for the development of new antibiotic combinations.
Preadaptation to a defined medium reduces the likelihood that adaptive mutations to antibiotic stress would enhance fitness in the absence of an antibiotic, as predicted by Fisher’s geometric model (79,80). This is a step that was only recently explored in Pseudomonas aeruginosa (12), and our transcriptional analysis extends beyond this effort. We distinguish our preadapted strains, which are kept in exponential phase, from strains deriving from the long-term evolution experiment in E. coli B, in which cells transition daily between exponential and stationary phase (66,77) and from unadapted strains in previous studies focused on nonextreme antagonistic interactions (34,81,82). The impact of preadaptation is illustrated in Fig. 2, A and B by the intersecting Ref and WT growth lines, which show that M9G-adaptive mutations can sensitize strains to the addition of rif. This finding stands in contrast with studies investigating random mutations (83,84), collateral drug resistance (81), and nutrient changes (85,86), which suggest that adaptive mutations desensitize strains to other stresses. Indeed, direct selection of mutations conferring antibiotic resistance from unadapted WT strains tends to yield mutations that are beneficial in both environments (87, 88, 89), including the D516G and H526Y mutations in E. coli cultivated in M9G (19). We suggest that the difference originates from a higher cost of selection (79) across environments of a different nature, which, in the case of our experiment, implies that the same mutation generally cannot provide fast growth in both environments (with and without rif). The compatibility between these contrasting results can indeed be appreciated by recognizing that previous studies have mainly compared the response to environments of the same nature, such as different antibiotics (12,43,81) or carbon sources (85,86). Indeed, antibiotic stress causes a targeted impairment of the cell’s biochemical network that does not necessarily have an equivalent in adaptation to a nutrient condition. Our demonstration that adaptation to a nonantibiotic condition sensitizes the organism to antibiotic stress is corroborated by recent experiments in Enterococcus faecalis (90), and in accordance with observations of nonreciprocating collateral sensitivity between carbenicillin and gentamycin (12), we anticipate that the order of adaptive steps matters.
A possible mechanism explaining this tradeoff between generalization and specialization is a difference in transcriptional dynamics (70,91,92). Generally, the transcriptional changes observed between Ref and Mut strains in the presence of rif highlight the transcriptome-wide impact of adaptation, whereas the changes in the absence of rif reflect the cost of resistance. The alignment changes in Fig. 6 suggest that termination could play a role in rif resistance, consistent with the observed changes in termination caused by mutations at the D516, H526, and I572 residues of rpoB (70). These findings may relate to rif resistance in M. tuberculosis (50), as recent work in that organism has implicated termination efficiency as the mechanism underlying the cost of resistance (51).
The experimental requirements to identify extreme antagonistic interactions are arguably more involved than those required to identify synergistic and merely antagonistic ones. Although we expect extreme antagonistic interactions to be large in number, they are also expected to be comparatively rare in the context of all interactions. This renders “reverse” genetic screening approaches, such as those based on libraries of gene knockouts (2, 3, 4, 5, 6), impractical because of the combinatorial explosion. Our “forward” genetic approach identifies point mutations that have pleiotropic effects on protein function in essential genes, which is a task that falls outside the scope of typical high-throughput approaches, and it is potentially massively parallelizable given advances in continuous culture and reductions in the cost of sequencing. Although high-throughput knockout experiments are not easily scalable in conjunction with preadaptation, future implementations of our approach could involve hybrid forward and reverse genetic approaches combined with mutagenesis techniques like TnSeq (5,93) to expand the range of possible extreme antagonistic responses.
The effects of mutations in extreme antagonistic interactions isolated in the second adaptive step constitute candidates for the development of antagonistic antibiotic partners for rif. This proposition is motivated by previous demonstrations that extreme antagonistically interacting drugs—in which the combination of two drugs is weaker than one of the drugs alone—can select against cells resistant to the suppressor drug (32,44,45). The mutations we identified can thus be regarded as targets for the design of one such partner for rif because a drug that emulates these mutations would suppress growth in M9G (thus acting as an antibiotic) and would alleviate growth defects in rif media (thus exhibiting an extreme antagonistic interaction with rif). In Fig. 2, C and D (bottom row), the region of antagonistic interactions corresponds to rif concentrations on the right side of the intersection between the lines. For example, for a rif partner corresponding to the Q148L mutation in rpoB(T1037P), resistance would reduce growth rate from 0.7 to 0.38 h−1 when the concentration of rif is 7.5 μM. The process of target identification for the design of drug partners can be further optimized by using error-prone polymerases (94) and other approaches that generate variability by manipulating selective pressure (95,96). Alternatively, after target genes have been characterized, partner drugs may be directly identified by screening small molecules that act on the target gene. We note that the rif-adaptive mutations in our experiments occur in rpoB, suggesting that RNAP will be the likely target of antagonistic partners of rif that can be developed to select against resistance.
Finally, although we have focused on pairwise gene-environment interactions, this study can also inform the development of methods to optimize the scheduling of drug treatments (33,34,43), and to identify higher order antagonistic interactions (47,97), in which the antagonism emerges between three or more genes and/or drugs. We anticipate that applications and generalizations of our approach will contribute to countering antibiotic resistance and advance our understanding of the role of antagonism in cellular networks (98) of multiple organisms.
Data and Materials Availability
All data necessary for the reproduction of the reported results are included in the Supporting Material. Materials used to obtain the results and computer code for performing the analysis are available from the authors upon reasonable request. Raw sequencing data have been deposited in the National Center for Biotechnology Information Sequence Read Archive under the submission number SRP220530 (BioProject PRJNA564142).
Author Contributions
T.P.W., A.J., S.C., and A.E.M. designed the research. M.Z. and A.F. performed the evolution experiments and mutational mapping analysis. T.P.W. analyzed and interpreted the transcriptomic and growth data. T.P.W. led the writing of the manuscript with contributions from all authors. All authors approved the final manuscript.
Acknowledgments
This research was supported by National Institutes of Health/National Institute of General Medical Sciences R01 GM113238.
Editor: Ido Golding.
Footnotes
Supporting Material can be found online at https://doi.org/10.1016/j.bpj.2020.09.038.
Supporting Material
References
- 1.Szathmáry E., Jordán F., Pál C. Can genes explain biological complexity? Science. 2001;292:1315–1316. doi: 10.1126/science.1060852. [DOI] [PubMed] [Google Scholar]
- 2.Tong A.H.Y., Lesage G., Boone C. Global mapping of the yeast genetic interaction network. Science. 2004;303:808–813. doi: 10.1126/science.1091317. [DOI] [PubMed] [Google Scholar]
- 3.Butland G., Babu M., Emili A. eSGA: E. coli synthetic genetic array analysis. Nat. Methods. 2008;5:789–795. doi: 10.1038/nmeth.1239. [DOI] [PubMed] [Google Scholar]
- 4.Typas A., Nichols R.J., Gross C.A. High-throughput, quantitative analyses of genetic interactions in E. coli. Nat. Methods. 2008;5:781–787. doi: 10.1038/nmeth.1240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.van Opijnen T., Bodi K.L., Camilli A. Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat. Methods. 2009;6:767–772. doi: 10.1038/nmeth.1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Costanzo M., VanderSluis B., Boone C. A global genetic interaction network maps a wiring diagram of cellular function. Science. 2016;353:aaf1420. doi: 10.1126/science.aaf1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ghim C.M., Goh K.I., Kahng B. Lethality and synthetic lethality in the genome-wide metabolic network of Escherichia coli. J. Theor. Biol. 2005;237:401–411. doi: 10.1016/j.jtbi.2005.04.025. [DOI] [PubMed] [Google Scholar]
- 8.Shlomi T., Berkman O., Ruppin E. Regulatory on/off minimization of metabolic flux changes after genetic perturbations. Proc. Natl. Acad. Sci. USA. 2005;102:7695–7700. doi: 10.1073/pnas.0406346102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Aziz R.K., Monk J.M., Charusanti P. Systems biology-guided identification of synthetic lethal gene pairs and its potential use to discover antibiotic combinations. Sci. Rep. 2015;5:16025. doi: 10.1038/srep16025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wood K.B., Cluzel P. Trade-offs between drug toxicity and benefit in the multi-antibiotic resistance system underlie optimal growth of E. coli. BMC Syst. Biol. 2012;6:48. doi: 10.1186/1752-0509-6-48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Imamovic L., Sommer M.O.A. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci. Transl. Med. 2013;5:204ra132. doi: 10.1126/scitranslmed.3006609. [DOI] [PubMed] [Google Scholar]
- 12.Barbosa C., Römhild R., Schulenburg H. Evolutionary stability of collateral sensitivity to antibiotics in the model pathogen Pseudomonas aeruginosa. eLife. 2019;8:e51481. doi: 10.7554/eLife.51481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mani R., St Onge R.P., Roth F.P. Defining genetic interaction. Proc. Natl. Acad. Sci. USA. 2008;105:3461–3466. doi: 10.1073/pnas.0712255105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lehner B. Molecular mechanisms of epistasis within and between genes. Trends Genet. 2011;27:323–331. doi: 10.1016/j.tig.2011.05.007. [DOI] [PubMed] [Google Scholar]
- 15.Snitkin E.S., Segrè D. Epistatic interaction maps relative to multiple metabolic phenotypes. PLoS Genet. 2011;7:e1001294. doi: 10.1371/journal.pgen.1001294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Reguly T., Breitkreutz A., Tyers M. Comprehensive curation and analysis of global interaction networks in Saccharomyces cerevisiae. J. Biol. 2006;5:11. doi: 10.1186/jbiol36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Motter A.E., Gulbahce N., Barabási A.L. Predicting synthetic rescues in metabolic networks. Mol. Syst. Biol. 2008;4:168. doi: 10.1038/msb.2008.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.McCloskey D., Xu S., Palsson B.O. Evolution of gene knockout strains of E. coli reveal regulatory architectures governed by metabolism. Nat. Commun. 2018;9:3796. doi: 10.1038/s41467-018-06219-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Wytock T.P., Fiebig A., Crosson S. Experimental evolution of diverse Escherichia coli metabolic mutants identifies genetic loci for convergent adaptation of growth rate. PLoS Genet. 2018;14:e1007284. doi: 10.1371/journal.pgen.1007284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Weinreich D.M., Watson R.A., Chao L. Perspective: sign epistasis and genetic constraint on evolutionary trajectories. Evolution. 2005;59:1165–1174. [PubMed] [Google Scholar]
- 21.Fraenkel D.G. Glycolysis, pentose phosphate pathway, and Entner-Doudoroff pathway. In: Neidhardt F.C., Ingraham J.L., Low K.B., Magasanik B., Schaechter M., Umbarger H.E., editors. Escherichia coli and Salmonella typhimurium: cellular and molecular biology. American Society for Microbiology; 1987. pp. 142–150. [Google Scholar]
- 22.Ashworth A., Lord C.J., Reis-Filho J.S. Genetic interactions in cancer progression and treatment. Cell. 2011;145:30–38. doi: 10.1016/j.cell.2011.03.020. [DOI] [PubMed] [Google Scholar]
- 23.Gerdes K., Maisonneuve E. Bacterial persistence and toxin-antitoxin loci. Annu. Rev. Microbiol. 2012;66:103–123. doi: 10.1146/annurev-micro-092611-150159. [DOI] [PubMed] [Google Scholar]
- 24.Farha M.A., Czarny T.L., Brown E.D. Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase. Proc. Natl. Acad. Sci. USA. 2015;112:11048–11053. doi: 10.1073/pnas.1511751112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Brown E.D., Wright G.D. Antibacterial drug discovery in the resistance era. Nature. 2016;529:336–343. doi: 10.1038/nature17042. [DOI] [PubMed] [Google Scholar]
- 26.Tamer Y.T., Gaszek I.K., Toprak E. High-order epistasis in catalytic power of dihydrofolate reductase gives rise to a rugged fitness landscape in the presence of trimethoprim selection. Mol. Biol. Evol. 2019;36:1533–1550. doi: 10.1093/molbev/msz086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Cornelius S.P., Lee J.S., Motter A.E. Dispensability of Escherichia coli’s latent pathways. Proc. Natl. Acad. Sci. USA. 2011;108:3124–3129. doi: 10.1073/pnas.1009772108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.González C., Ray J.C.J., Balázsi G. Stress-response balance drives the evolution of a network module and its host genome. Mol. Syst. Biol. 2015;11:827. doi: 10.15252/msb.20156185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kheir Gouda M., Manhart M., Balázsi G. Evolutionary regain of lost gene circuit function. Proc. Natl. Acad. Sci. USA. 2019;116:25162–25171. doi: 10.1073/pnas.1912257116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Motter A.E. Improved network performance via antagonism: from synthetic rescues to multi-drug combinations. BioEssays. 2010;32:236–245. doi: 10.1002/bies.200900128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Pena-Miller R., Laehnemann D., Beardmore R. When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition. PLoS Biol. 2013;11:e1001540. doi: 10.1371/journal.pbio.1001540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Baym M., Stone L.K., Kishony R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science. 2016;351:aad3292. doi: 10.1126/science.aad3292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Iram S., Dolson E., Hinczewski M. Controlling the speed and trajectory of evolution with counterdiabatic driving. bioRxiv. 2020 doi: 10.1101/867143. [DOI] [Google Scholar]
- 34.Maltas J., Wood K.B. Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance. PLoS Biol. 2019;17:e3000515. doi: 10.1371/journal.pbio.3000515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nichol D., Rutter J., Scott J.G. Antibiotic collateral sensitivity is contingent on the repeatability of evolution. Nat. Commun. 2019;10:334. doi: 10.1038/s41467-018-08098-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Dean Z., Maltas J., Wood K.B. Antibiotic interactions shape short-term evolution of resistance in E. faecalis. PLoS Pathog. 2020;16:e1008278. doi: 10.1371/journal.ppat.1008278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lindsey H.A., Gallie J., Kerr B. Evolutionary rescue from extinction is contingent on a lower rate of environmental change. Nature. 2013;494:463–467. doi: 10.1038/nature11879. [DOI] [PubMed] [Google Scholar]
- 38.Enne V.I., Delsol A.A., Bennett P.M. Rifampicin resistance and its fitness cost in Enterococcusfaecium. J. Antimicrob. Chemother. 2004;53:203–207. doi: 10.1093/jac/dkh044. [DOI] [PubMed] [Google Scholar]
- 39.Paulander W., Maisnier-Patin S., Andersson D.I. The fitness cost of streptomycin resistance depends on rpsL mutation, carbon source and RpoS (σS) Genetics. 2009;183:539–546. doi: 10.1534/genetics.109.106104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Maharjan R., Ferenci T. The fitness costs and benefits of antibiotic resistance in drug-free microenvironments encountered in the human body. Environ. Microbiol. Rep. 2017;9:635–641. doi: 10.1111/1758-2229.12564. [DOI] [PubMed] [Google Scholar]
- 41.Bollenbach T., Quan S., Kishony R. Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell. 2009;139:707–718. doi: 10.1016/j.cell.2009.10.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Quan S., Ray J.C.J., Monds R.D. Adaptive evolution of the lactose utilization network in experimentally evolved populations of Escherichia coli. PLoS Genet. 2012;8:e1002444. doi: 10.1371/journal.pgen.1002444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Roemhild R., Gokhale C.S., Schulenburg H. Cellular hysteresis as a principle to maximize the efficacy of antibiotic therapy. Proc. Natl. Acad. Sci. USA. 2018;115:9767–9772. doi: 10.1073/pnas.1810004115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Blagosklonny M.V. Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal. Leukemia. 1999;13:2031–2035. doi: 10.1038/sj.leu.2401623. [DOI] [PubMed] [Google Scholar]
- 45.Chait R., Craney A., Kishony R. Antibiotic interactions that select against resistance. Nature. 2007;446:668–671. doi: 10.1038/nature05685. [DOI] [PubMed] [Google Scholar]
- 46.Yin N., Ma W., Lai L. Synergistic and antagonistic drug combinations depend on network topology. PLoS One. 2014;9:e93960. doi: 10.1371/journal.pone.0093960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zimmer A., Katzir I., Alon U. Prediction of multidimensional drug dose responses based on measurements of drug pairs. Proc. Natl. Acad. Sci. USA. 2016;113:10442–10447. doi: 10.1073/pnas.1606301113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Palmer A.C., Chait R., Kishony R. Nonoptimal gene expression creates latent potential for antibiotic resistance. Mol. Biol. Evol. 2018;35:2669–2684. doi: 10.1093/molbev/msy163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Lázár V., Nagy I., Pál C. Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network. Nat. Commun. 2014;5:4352. doi: 10.1038/ncomms5352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Comas I., Borrell S., Gagneux S. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat. Genet. 2011;44:106–110. doi: 10.1038/ng.1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Stefan M.A., Ugur F.S., Garcia G.A. Source of the fitness defect in rifamycin-resistant Mycobacterium tuberculosis RNA polymerase and the mechanism of compensation by mutations in the β′ subunit. Antimicrob. Agents Chemother. 2018;62:e00164-18. doi: 10.1128/AAC.00164-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA. 2000;97:6640–6645. doi: 10.1073/pnas.120163297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Lee H., Popodi E., Foster P.L. Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing. Proc. Natl. Acad. Sci. USA. 2012;109:E2774–E2783. doi: 10.1073/pnas.1210309109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Deatherage D.E., Barrick J.E. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol. 2014;1151:165–188. doi: 10.1007/978-1-4939-0554-6_12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Zhu A., Ibrahim J.G., Love M.I. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics. 2019;35:2084–2092. doi: 10.1093/bioinformatics/bty895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Mi H., Muruganujan A., Thomas P.D. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419–D426. doi: 10.1093/nar/gky1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Galperin M.Y., Makarova K.S., Koonin E.V. Expanded microbial genome coverage and improved protein family annotation in the COG database. Nucleic Acids Res. 2015;43:D261–D269. doi: 10.1093/nar/gku1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Benjamini Y., Drai D., Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 2001;125:279–284. doi: 10.1016/s0166-4328(01)00297-2. [DOI] [PubMed] [Google Scholar]
- 59.Santos-Zavaleta A., Salgado H., Collado-Vides J. RegulonDB v 10.5: tackling challenges to unify classic and high throughput knowledge of gene regulation in E. coli K-12. Nucleic Acids Res. 2019;47:D212–D220. doi: 10.1093/nar/gky1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Durfee T., Hansen A.M., Jin D.J. Transcription profiling of the stringent response in Escherichia coli. J. Bacteriol. 2008;190:1084–1096. doi: 10.1128/JB.01092-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Balázsi G., Barabási A.L., Oltvai Z.N. Topological units of environmental signal processing in the transcriptional regulatory network of Escherichia coli. Proc. Natl. Acad. Sci. USA. 2005;102:7841–7846. doi: 10.1073/pnas.0500365102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Sastry A.V., Gao Y., Palsson B.O. The Escherichia coli transcriptome mostly consists of independently regulated modules. Nat. Commun. 2019;10:5536. doi: 10.1038/s41467-019-13483-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Vvedenskaya I.O., Vahedian-Movahed H., Nickels B.E. Interactions between RNA polymerase and the “core recognition element” counteract pausing. Science. 2014;344:1285–1289. doi: 10.1126/science.1253458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Di Salvo M., Puccio S., Alifano P. RhoTermPredict: an algorithm for predicting Rho-dependent transcription terminators based on Escherichia coli, Bacillussubtilis and Salmonella enterica databases. BMC Bioinformatics. 2019;20:117. doi: 10.1186/s12859-019-2704-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Wang B., Zhang X., Zhao X. Evolutionary engineering of Escherichia coli for improved anaerobic growth in minimal medium accelerated lactate production. Appl. Microbiol. Biotechnol. 2019;103:2155–2170. doi: 10.1007/s00253-018-09588-9. [DOI] [PubMed] [Google Scholar]
- 66.Woods R., Schneider D., Lenski R.E. Tests of parallel molecular evolution in a long-term experiment with Escherichia coli. Proc. Natl. Acad. Sci. USA. 2006;103:9107–9112. doi: 10.1073/pnas.0602917103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Campbell E.A., Korzheva N., Darst S.A. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell. 2001;104:901–912. doi: 10.1016/s0092-8674(01)00286-0. [DOI] [PubMed] [Google Scholar]
- 68.Zhou Y.N., Lubkowska L., Kashlev M. Isolation and characterization of RNA polymerase rpoB mutations that alter transcription slippage during elongation in Escherichia coli. J. Biol. Chem. 2013;288:2700–2710. doi: 10.1074/jbc.M112.429464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Trautinger B.W., Lloyd R.G. Modulation of DNA repair by mutations flanking the DNA channel through RNA polymerase. EMBO J. 2002;21:6944–6953. doi: 10.1093/emboj/cdf654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Jin D.J., Walter W.A., Gross C.A. Characterization of the termination phenotypes of rifampicin-resistant mutants. J. Mol. Biol. 1988;202:245–253. doi: 10.1016/0022-2836(88)90455-x. [DOI] [PubMed] [Google Scholar]
- 71.Garibyan L., Huang T., Miller J.H. Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair (Amst.) 2003;2:593–608. doi: 10.1016/s1568-7864(03)00024-7. [DOI] [PubMed] [Google Scholar]
- 72.Jin D.J., Gross C.A. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 1988;202:45–58. doi: 10.1016/0022-2836(88)90517-7. [DOI] [PubMed] [Google Scholar]
- 73.Ederth J., Mooney R.A., Landick R. Functional interplay between the jaw domain of bacterial RNA polymerase and allele-specific residues in the product RNA-binding pocket. J. Mol. Biol. 2006;356:1163–1179. doi: 10.1016/j.jmb.2005.11.080. [DOI] [PubMed] [Google Scholar]
- 74.Ross W., Vrentas C.E., Gourse R.L. The magic spot: a ppGpp binding site on E. coli RNA polymerase responsible for regulation of transcription initiation. Mol. Cell. 2013;50:420–429. doi: 10.1016/j.molcel.2013.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Basan M., Hui S., Hwa T. Overflow metabolism in Escherichia coli results from efficient proteome allocation. Nature. 2015;528:99–104. doi: 10.1038/nature15765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Hall A.R., Iles J.C., MacLean R.C. The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase. Genetics. 2011;187:817–822. doi: 10.1534/genetics.110.124628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Barrick J.E., Kauth M.R., Lenski R.E. Escherichia colirpoB mutants have increased evolvability in proportion to their fitness defects. Mol. Biol. Evol. 2010;27:1338–1347. doi: 10.1093/molbev/msq024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Qi Q., Toll-Riera M., MacLean R.C. The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonasaeruginosa. Proc. Biol. Sci. 2016;283:20152452. doi: 10.1098/rspb.2015.2452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Hietpas R.T., Bank C., Bolon D.N.A. Shifting fitness landscapes in response to altered environments. Evolution. 2013;67:3512–3522. doi: 10.1111/evo.12207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Blanquart F., Achaz G., Tenaillon O. Properties of selected mutations and genotypic landscapes under Fisher’s geometric model. Evolution. 2014;68:3537–3554. doi: 10.1111/evo.12545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Trindade S., Sousa A., Gordo I. Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet. 2009;5:e1000578. doi: 10.1371/journal.pgen.1000578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Clarke L., Pelin A., Wong A. The effect of environmental heterogeneity on the fitness of antibiotic resistance mutations in Escherichia coli. Evol. Ecol. 2020;34:379–390. [Google Scholar]
- 83.Kishony R., Leibler S. Environmental stresses can alleviate the average deleterious effect of mutations. J. Biol. 2003;2:14. doi: 10.1186/1475-4924-2-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Remold S.K., Lenski R.E. Pervasive joint influence of epistasis and plasticity on mutational effects in Escherichia coli. Nat. Genet. 2004;36:423–426. doi: 10.1038/ng1324. [DOI] [PubMed] [Google Scholar]
- 85.Conrad T.M., Frazier M., Palsson B.Ø. RNA polymerase mutants found through adaptive evolution reprogram Escherichia coli for optimal growth in minimal media. Proc. Natl. Acad. Sci. USA. 2010;107:20500–20505. doi: 10.1073/pnas.0911253107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Hall A.E., Karkare K., Moore F.B. Environment changes epistasis to alter trade-offs along alternative evolutionary paths. Evolution. 2019;73:2094–2105. doi: 10.1111/evo.13825. [DOI] [PubMed] [Google Scholar]
- 87.Angst D.C., Hall A.R. The cost of antibiotic resistance depends on evolutionary history in Escherichia coli. BMC Evol. Biol. 2013;13:163. doi: 10.1186/1471-2148-13-163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Hall A.R. Genotype-by-environment interactions due to antibiotic resistance and adaptation in Escherichia coli. J. Evol. Biol. 2013;26:1655–1664. doi: 10.1111/jeb.12172. [DOI] [PubMed] [Google Scholar]
- 89.Sabarly V., Aubron C., Dillmann C. Interactions between genotype and environment drive the metabolic phenotype within Escherichia coli isolates. Environ. Microbiol. 2016;18:100–117. doi: 10.1111/1462-2920.12855. [DOI] [PubMed] [Google Scholar]
- 90.Maltas J., Krasnick B., Wood K.B. Using selection by nonantibiotic stressors to sensitize bacteria to antibiotics. Mol. Biol. Evol. 2020;37:1394–1406. doi: 10.1093/molbev/msz303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Landick R. The regulatory roles and mechanism of transcriptional pausing. Biochem. Soc. Trans. 2006;34:1062–1066. doi: 10.1042/BST0341062. [DOI] [PubMed] [Google Scholar]
- 92.Klumpp S., Hwa T. Stochasticity and traffic jams in the transcription of ribosomal RNA: intriguing role of termination and antitermination. Proc. Natl. Acad. Sci. USA. 2008;105:18159–18164. doi: 10.1073/pnas.0806084105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Roux D., Danilchanka O., Skurnik D. Fitness cost of antibiotic susceptibility during bacterial infection. Sci. Transl. Med. 2015;7:297ra114. doi: 10.1126/scitranslmed.aab1621. [DOI] [PubMed] [Google Scholar]
- 94.Poelwijk F.J., de Vos M.G., Tans S.J. Tradeoffs and optimality in the evolution of gene regulation. Cell. 2011;146:462–470. doi: 10.1016/j.cell.2011.06.035. [DOI] [PubMed] [Google Scholar]
- 95.Hao Y.Q., Brockhurst M.A., Zhang Q.G. Evolutionary rescue can be impeded by temporary environmental amelioration. Ecol. Lett. 2015;18:892–898. doi: 10.1111/ele.12465. [DOI] [PubMed] [Google Scholar]
- 96.Steinberg B., Ostermeier M. Environmental changes bridge evolutionary valleys. Sci. Adv. 2016;2:e1500921. doi: 10.1126/sciadv.1500921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Lukačišin M., Bollenbach T. Emergent gene expression responses to drug combinations predict higher-order drug interactions. Cell Syst. 2019;9:423–433. doi: 10.1016/j.cels.2019.10.004. [DOI] [PubMed] [Google Scholar]
- 98.Kemble H., Nghe P., Tenaillon O. Recent insights into the genotype-phenotype relationship from massively parallel genetic assays. Evol. Appl. 2019;12:1721–1742. doi: 10.1111/eva.12846. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






